Canon Electronics Inc. (CAOEF)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2024	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	712	623	593	470	563	593
Market Cap Growth	25.90%	5.04%	26.17%	-16.52%	-5.13%	-24.88%
Enterprise Value	511	299	414	364	384	400
Last Close Price	16.17	16.17	12.97	-	-	-
PE Ratio	14.19	12.79	12.73	8.95	12.02	13.88
PS Ratio	1.00	0.97	0.87	0.64	0.78	0.82
PB Ratio	0.84	0.80	0.73	0.56	0.63	0.63
P/TBV Ratio	0.85	0.81	0.74	0.59	0.66	0.65
P/FCF Ratio	12.18	8.98	11.89	-	-	63.06
P/OCF Ratio	9.95	7.71	8.19	14.88	23.62	11.55
EV/Sales Ratio	0.73	0.47	0.61	0.50	0.54	0.55
EV/EBITDA Ratio	6.16	3.50	4.70	4.10	4.60	4.83
EV/EBIT Ratio	8.05	4.52	6.38	5.96	6.96	7.37
EV/FCF Ratio	8.75	4.31	8.30	-	-	42.53
Debt / Equity Ratio	0.01	0.01	0.00	0.04	0.03	0.02
Debt / EBITDA Ratio	-	0.06	0.01	0.37	0.35	0.27
Debt / FCF Ratio	0.09	0.08	0.02	-	-	2.37
Asset Turnover	0.73	0.74	0.72	0.73	0.68	0.64
Inventory Turnover	5.91	6.13	5.35	5.83	7.22	9.62
Quick Ratio	3.08	3.25	3.32	2.57	2.54	3.22
Current Ratio	4.02	4.14	5.68	4.38	4.35	5.35
Return on Equity (ROE)	6.04%	6.51%	5.31%	5.02%	4.41%	4.04%
Return on Assets (ROA)	4.59%	4.76%	4.25%	3.81%	3.26%	3.01%
Return on Capital (ROIC)	5.35%	5.49%	4.98%	4.53%	3.85%	3.58%
Return on Capital Employed (ROCE)	8.30%	8.40%	7.90%	6.90%	5.90%	5.40%
Earnings Yield	7.05%	7.82%	7.86%	11.17%	8.32%	7.21%
FCF Yield	8.21%	11.14%	8.41%	-1.35%	-4.31%	1.59%
Dividend Yield	2.87%	2.75%	3.28%	-	-	-
Payout Ratio	-	34.70%	37.41%	32.49%	37.95%	55.59%
Buyback Yield / Dilution	-0.04%	-0.03%	-0.03%	-0.03%	-0.03%	-0.04%
Total Shareholder Return	2.83%	2.72%	3.25%	-0.03%	-0.03%	-0.04%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.